philanthropy in action dsip Should Invest Capacity of Government Institutions How Donor Funding Drives Major
Description
No specific contraindications for combination therapies have been established, but prudent clinical practice suggests monitoring for unexpected interactions when initiating novel combination regimens
Pacini S, Fiore MG, Magherini S, Morucci G, Branca JJ, Gulisano M, et al

(JD Supra) For clinics, prescribers, and compounders, the stakes are blunt: if PCAC and FDA say no, access shifts further to offshore suppliers and domestic gray-market sellers

Yin B-K, Lzaro D, Wang Z-Q

This statutory exclusion cannot be overridden by appeals or exception requests
